Abstract:Tumor tissue samples comprise a mixture of cancerous and surrounding stromal cells. Understanding tumor heterogeneity is crucial to analyzing gene signatures associated with cancer prognosis and treatment decisions. Compared with the experimental approach of using laser micro-dissection to isolate different tissue components, in silico dissection of mixed cell samples is faster and cheaper. Numerous computational approaches previously developed have limited ability to deconvolute heterogeneous tumor samples. We have developed a deconvolution model, DeMix-T, that can explicitly account for a third component such as infiltrating immune cells, and address this challenging problem when the observed signals are assumed to come from a mixture of three cell compartments, infiltrating immune cells, the tumor microenvironment and cancerous tissues. The optimization-based algorithm for DeMix-T finds a local optimum for our estimation problem and is computationally feasible when it needs to compute high-dimensional integrals. DeMix-T therefore involves a novel two-stage filtering method that yields accurate estimates of cell purities and compartment-specific expression profiles. Simulations and real data analyses have demonstrated the good performance of our method. Compared with other deconvolution tools, DeMix-T can be applied more widely and provides deeper insight for cancer biomarker studies. It allows for a further understanding of immune cell infiltration in cancer and assists in the development of novel prognostic markers and therapeutic strategies. Citation Format: Zeya Wang, Jeffrey S. Morris, Chris C. Holmes, Jaeil Ahn, Bo Li, Wei Lu, Ximing Tang, Ignacio I. Wistuba, Wenyi Wang. Cell type-specific deconvolution of heterogeneous tumor samples with immune infiltration using expression data. [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14 Suppl):Abstract nr 2413.

Partially-independent component analysis for tissue heterogeneity correction in microarray gene expression analysis

PART I ALLY- IN DE P E N DENT C 0 M P 0 N ENT ANALYSIS FOR TISSUE HETEROGENEITY CORRECTION IN MICROARRAY GENE EXPRESSION ANALYSIS

In silico microdissection of microarray data from heterogeneous cell populations

Independent Component Analysis-Based Penalized Discriminant Method for Tumor Classification Using Gene Expression Data.

Unraveling the hidden heterogeneities of breast cancer based on functional miRNA cluster.

Multi-Class Cancer Classification by Total Principal Component Regression (tpcr) Using Microarray Gene Expression Data

Dissecting tumor transcriptional heterogeneity from single-cell RNA-seq data by generalized binary covariance decomposition

Independent component analysis-based penalized discriminant method for tumor classification using gene expression data

Incorporating prior information in gene expression network-based cancer heterogeneity analysis

Molecular Diagnosis of Tumor Based on Independent Component Analysis and Support Vector Machines

Gene Expression Data Classification Using Consensus Independent Component Analysis

Molecular Diagnosis of Human Cancer Type by Gene Expression Profiles and Independent Component Analysis

Identification of Differentially Expressed Genes Using Disjoint Principal Component Analysis Coupled with Genetic Algorithm

Cancer classification based on microarray gene expression data using a principal component accumulation method

Subtype Dependent Biomarker Identification and Tumor Classification from Gene Expression Profiles.

Computational Methods for Gene Expression-Based Tumor Classification

Cell Type-Specific Deconvolution Of Heterogeneous Tumor Samples With Immune Infiltration Using Expression Data

Cell Heterogeneity Analysis in Single-Cell RNA-seq Data Using Mixture Exponential Graph and Markov Random Field Model

Heterogeneity Analysis Via Integrating Multi-Sources High-Dimensional Data with Applications to Cancer Studies

A Case Study on the Identification of Confounding Factors for Gene Disease Association Analysis.

Joint Discriminatory Gene Selection for Molecular Classification of Cancer